Subscribe to RSS
DOI: 10.1055/a-2646-1987
Polydatin as a Potential Therapeutic in Pediatric Intestinal Volvulus: Evidence from an Experimental I/R Injury Model
Funding None.

Abstract
Introduction
Small bowel volvulus is a clinical condition that causes intestinal ischemia–reperfusion (I/R) injury, leading to severe tissue damage and high mortality rates. Polydatin, a natural stilbenoid polyphenol, has demonstrated anti-inflammatory and antioxidant properties. This study aimed to evaluate the protective effects of polydatin on I/R injury using an experimental small bowel volvulus model.
Materials and Methods
A total of 24 healthy female Wistar albino rats were divided into four groups: Sham (Group 1), Polydatin (Group 2), I/R (Group 3), and Treatment (Group 4). In Group 1, no I/R procedure was applied, and intraperitoneal saline was administered. Group 2 received 20 mg/kg intraperitoneal polydatin without I/R. In Group 3, a 5-cm segment of the small intestine was twisted 360 degrees clockwise, leading to 2 hours of ischemia and 2 hours of reperfusion. Group 4 received 20 mg/kg intraperitoneal polydatin before reperfusion. Blood and intestinal tissue samples were collected for biochemical and histopathological analysis.
Results
Serum total antioxidant status (TAS) levels were significantly higher in the treatment group compared with the I/R group (p = 0.004). Serum total oxidant status (TOS) levels were significantly elevated in the I/R group compared with all other groups (p < 0.001) but were significantly reduced in the treatment group (p < 0.001). Tissue oxidative stress index (OSI) values were significantly lower in the treatment group compared with the I/R group (p = 0.004). Although serum OSI levels and tissue TAS and TOS values showed a favorable trend, they were not statistically significant. Histopathological evaluations revealed a marked reduction in tissue damage in the treatment group compared with the I/R group.
Conclusion
Polydatin exerts protective effects against I/R injury in an experimental small bowel volvulus model by reducing oxidative stress and histopathological damage. These findings highlight its therapeutic potential and warrant further clinical research.
Publication History
Received: 07 April 2025
Accepted: 29 June 2025
Article published online:
15 July 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Burda R, Burda J, Morochovič R. Ischemic tolerance—a way to reduce the extent of ischemia-reperfusion damage. Cells 2023; 12 (06) 884
- 2 Gonzalez LM, Moeser AJ, Blikslager AT. Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research. Am J Physiol Gastrointest Liver Physiol 2015; 308 (02) G63-G75
- 3 Allan Z, Wong DJ, Sweeney T, Liu DS. Congenital midgut malrotation predisposing to small bowel volvulus around left-sided feeding jejunostomy. ANZ J Surg 2022; 92 (7-8): 1896-1898
- 4 Papadimitriou G, Marinis A, Papakonstantinou A. Primary midgut volvulus in adults: report of two cases and review of the literature. J Gastrointest Surg 2011; 15 (10) 1889-1892
- 5 Li X, Zhang J, Li B. et al. Diagnosis, treatment and prognosis of small bowel volvulus in adults: a monocentric summary of a rare small intestinal obstruction. PLoS One 2017; 12 (04) e0175866
- 6 El Nogoomi I, Jumah R, Zaidan KO, Agha A. Primary midgut volvulus: an unusual case of a young adult necessitating extensive bowel resection. Cureus 2024; 16 (02) e54472
- 7 Sun Z, Wang X. Protective effects of polydatin on multiple organ ischemia-reperfusion injury. Bioorg Chem 2020; 94: 103485
- 8 Karami A, Fakhri S, Kooshki L, Khan H. Polydatin: pharmacological mechanisms, therapeutic targets, biological activities, and health benefits. Molecules 2022; 27 (19) 6474
- 9 Yu Y, Klemann C, Feng X. et al. Increased inflammatory reaction to intestinal ischemia-reperfusion in neonatal versus adult mice. Eur J Pediatr Surg 2015; 25 (01) 46-50
- 10 Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970; 101 (04) 478-483
- 11 Sukhotnik I, Ben Shahar Y, Halabi S. et al. Effect of N-acetylserotonin on TLR-4 and MyD88 expression during intestinal ischemia-reperfusion in a rat model. Eur J Pediatr Surg 2019; 29 (02) 188-195
- 12 Oral H, Türkyılmaz Z, Karabulut R. et al. Protective effects of hydrogen-rich saline on experimental intestinal volvulus in rats. J Invest Surg 2022; 35 (07) 1427-1433
- 13 Doğan G, İpek H, Baş Y, Doğan G, Kayır S. Experimental study on prophylactic effects of vardenafil in ischemia-reperfusion model with intestinal volvulus injury in rats. J Pediatr Surg 2019; 54 (10) 2172-2177
- 14 Wang L, Gao R, Li B. et al. Human breast milk-derived exosomes protect against intestinal ischemia and reperfusion injury in neonatal rats. J Pediatr Surg 2022; 57 (07) 1264-1268
- 15 Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, Fuggetta MP. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 2012; 35 (01) 240-248
- 16 Du J, Sun LN, Xing WW. et al. Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters. Phytomedicine 2009; 16 (6-7): 652-658
- 17 Sun Z, Wang Y, Pang X, Wang X, Zeng H. Mechanisms of polydatin against spinal cord ischemia-reperfusion injury based on network pharmacology, molecular docking and molecular dynamics simulation. Bioorg Chem 2023; 140: 106840
- 18 Bian HN, Sun CW, Chen HD, Zheng SY, Liu ZA, Lai W. Effects of polydatin on the biological features of cultured fibroblasts. Chin J Tissue Engineer Res 2012; 16 (33) 6111-6115
- 19 Chen L, Lan Z, Lin Q. et al. Polydatin ameliorates renal injury by attenuating oxidative stress-related inflammatory responses in fructose-induced urate nephropathic mice. Food Chem Toxicol 2013; 52: 28-35
- 20 Cheng Y, Zhang HT, Sun L. et al. Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury. Brain Res 2006; 1110 (01) 193-200
- 21 Du QH, Peng C, Zhang H. Polydatin: a review of pharmacology and pharmacokinetics. Pharm Biol 2013; 51 (11) 1347-1354
- 22 Meng QH, Liu HB, Wang JB. Polydatin ameliorates renal ischemia/reperfusion injury by decreasing apoptosis and oxidative stress through activating sonic hedgehog signaling pathway. Food Chem Toxicol 2016; 96: 215-225
- 23 Qiao H, Ma H, Cao W, Chen H, Wei J, Li Z. Protective effects of polydatin on experimental testicular torsion and detorsion injury in rats. Reprod Fertil Dev 2017; 29 (12) 2367-2375
- 24 Wang R, Pan T, Huang L. et al. Photoacoustic imaging in evaluating early intestinal ischemia injury and reperfusion injury in rat models. Quant Imaging Med Surg 2021; 11 (07) 2968-2979
- 25 Zhou QL, Qin RZ, Yang YX, Huang KB, Yang XW. Polydatin possesses notable anti-osteoporotic activity via regulation of OPG, RANKL and β-catenin. Mol Med Rep 2016; 14 (02) 1865-1869
- 26 Chen FY, Fang XY, Zhang H. Effect of polydatin on expression of p53 and Notch1 in brain tissue of ischemic cerebrovascular disease. J Biol Regul Homeost Agents 2018; 32 (01) 133-138
- 27 Taskiran A, Eskiocak S, Cikirikcioglu M, Ege T, Duran E. The relationship between preoperative plasma total antioxidant capacity and ischemia-reperfusion injury in patients undergoing coronary artery bypass surgery. Balkan Med J 2005; 22: 16-22
- 28 Leon F, Grandi F, Cavicchiolo M, Ghidini F, Verlato G. Urokinase thrombolysis as a rescue treatment for midgut volvulus ischemia. J Pediatr Surg Case Rep 2017; 23: 29-31